Inhibition of Ovarian Cancer Cell Proliferation by Pien Tze Huang Via the AKT-mTOR Pathway

Overview

Journal Oncol Lett

Specialty Oncology

Date 2014 Jun 17

PMID 24932287

Citations 13

Authors

Fan He

Hui-Ni Wu

Mu-Yan Cai

Chang-Peng Li

Xin Zhang

Quan Wan

Shuang-Bo Tang

Jian-Ding Cheng

Affiliations

Soon will be listed here.

Abstract

Pien Tze Huang (PZH) is a well-known Chinese medicine that has been used as a therapeutic drug in the treatment of a number of diseases, such as hepatocellular carcinoma and colon cancer. However, few studies have analyzed the effects of PZH on ovarian cancer cell proliferation. In the present study, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide and Transwell assays, cell cycle and apoptosis rate analyses and western blotting were conducted to investigate the effects of PZH on the proliferation rate of ovarian cancer cells and its potential molecular pathway. The results showed that PZH inhibits the proliferation of the human ovarian cancer OVCAR-3 cell line by blocking the progression of the cell cycle from the G to S phase, however, PZH did not induce OVCAR-3 cell apoptosis. Increased PZH concentration may downregulate the expression of AKT, phosphorylated (p)-AKT, mammalian target of rapamycin (mTOR) and p-mTOR proteins in the OVCAR-3 cell line. In addition, it was observed that PZH may suppress the protein expression of cyclin-dependent kinase (CDK)4 and CDK6. Overall, the results of the present study indicated that PZH may inhibit ovarian cancer cell proliferation by modulating the activity of the AKT-mTOR pathway.

Citing Articles

Therapeutic potential of Pien Tze Huang in colitis-associated colorectal cancer: mechanistic insights from a mouse model.

Liu L, Chen Y, Liu S, Zhang X, Cao L, Wu Y Cancer Cell Int. 2024; 24(1):250.

PMID: 39020410 PMC: 11256454. DOI: 10.1186/s12935-024-03428-9.

Pien Tze Huang Inhibits Proliferation of Colorectal Cancer Cells through Suppressing PNO1 Expression and Activating p53/p21 Signaling Pathway.

Cao L, Liu L, Chen Y, Han Y, Wei L, Yao M Chin J Integr Med. 2024; 30(6):515-524.

PMID: 38216838 DOI: 10.1007/s11655-024-3709-5.

Ethyl Acetate Extract of Induced Apoptosis, Autophagy, and Cell Cycle Arrest in Colorectal Cancer Cells.

Chantree P, Martviset P, Sornchuer P, Thongsepee N, Sangpairoj K, Meemon K Prev Nutr Food Sci. 2023; 28(1):69-78.

PMID: 37066031 PMC: 10103606. DOI: 10.3746/pnf.2023.28.1.69.

Pien Tze Huang Inhibits Migration and Invasion of Hepatocellular Carcinoma Cells by Repressing PDGFRB/YAP/CCN2 Axis Activity.

Luo Z, Tian Q, Cheng N, Liu W, Yang Y, Chen W Chin J Integr Med. 2022; 30(2):115-124.

PMID: 35947230 DOI: 10.1007/s11655-022-3533-8.

Pien Tze Huang (PZH) as a Multifunction Medicinal Agent in Traditional Chinese Medicine (TCM): a review on cellular, molecular and physiological mechanisms.

Chen Z Cancer Cell Int. 2021; 21(1):146.

PMID: 33658028 PMC: 7931540. DOI: 10.1186/s12935-021-01785-3.

References

Sha O, Niu J, Ng T, Cho E, Fu X, Jiang W . Anti-tumor action of trichosanthin, a type 1 ribosome-inactivating protein, employed in traditional Chinese medicine: a mini review. Cancer Chemother Pharmacol. 2013; 71(6):1387-93. PMC: 3668121. DOI: 10.1007/s00280-013-2096-y. View

Fingar D, Blenis J . Target of rapamycin (TOR): an integrator of nutrient and growth factor signals and coordinator of cell growth and cell cycle progression. Oncogene. 2004; 23(18):3151-71. DOI: 10.1038/sj.onc.1207542. View

Shen A, Hong F, Liu L, Lin J, Zhuang Q, Hong Z . Effects of Pien Tze Huang on angiogenesis in vivo and in vitro. Chin J Integr Med. 2012; 18(6):431-6. DOI: 10.1007/s11655-012-1121-z. View

Ferlay J, Parkin D, Steliarova-Foucher E . Estimates of cancer incidence and mortality in Europe in 2008. Eur J Cancer. 2010; 46(4):765-81. DOI: 10.1016/j.ejca.2009.12.014. View

Bartek J, Lukas J . Mammalian G1- and S-phase checkpoints in response to DNA damage. Curr Opin Cell Biol. 2001; 13(6):738-47. DOI: 10.1016/s0955-0674(00)00280-5. View

Oldham S, Montagne J, Radimerski T, Thomas G, Hafen E . Genetic and biochemical characterization of dTOR, the Drosophila homolog of the target of rapamycin. Genes Dev. 2000; 14(21):2689-94. PMC: 317036. DOI: 10.1101/gad.845700. View

Yang Q, Guan K . Expanding mTOR signaling. Cell Res. 2007; 17(8):666-81. DOI: 10.1038/cr.2007.64. View

Guertin D, Sabatini D . Defining the role of mTOR in cancer. Cancer Cell. 2007; 12(1):9-22. DOI: 10.1016/j.ccr.2007.05.008. View

Chan J, Cheung J, Luk S, Wu Y, Pang S, Fung K . Anti-cancer and pro-apoptotic effects of an herbal medicine and Saccharomyces cerevisiae product (CKBM) on human hepatocellular carcinoma HepG2 cells in vitro and in vivo. Immunopharmacol Immunotoxicol. 2005; 26(4):597-609. DOI: 10.1081/iph-200042357. View

10.

Hleb M, Murphy S, Wagner E, Hanna N, Sharma N, Park J . Evidence for cyclin D3 as a novel target of rapamycin in human T lymphocytes. J Biol Chem. 2004; 279(30):31948-55. DOI: 10.1074/jbc.M400638200. View

11.

Li X, Yang G, Li X, Zhang Y, Yang J, Chang J . Traditional Chinese medicine in cancer care: a review of controlled clinical studies published in chinese. PLoS One. 2013; 8(4):e60338. PMC: 3616129. DOI: 10.1371/journal.pone.0060338. View

12.

Montagne J, Stewart M, Stocker H, Hafen E, Kozma S, Thomas G . Drosophila S6 kinase: a regulator of cell size. Science. 1999; 285(5436):2126-9. DOI: 10.1126/science.285.5436.2126. View

13.

Madan E, Gogna R, Bhatt M, Pati U, Kuppusamy P, Mahdi A . Regulation of glucose metabolism by p53: emerging new roles for the tumor suppressor. Oncotarget. 2012; 2(12):948-57. PMC: 3282098. DOI: 10.18632/oncotarget.389. View

14.

Angioli R, Palaia I, Zullo M, Muzii L, Manci N, Calcagno M . Diagnostic open laparoscopy in the management of advanced ovarian cancer. Gynecol Oncol. 2005; 100(3):455-61. DOI: 10.1016/j.ygyno.2005.09.060. View

15.

Hedberg Y, Ljungberg B, Roos G, Landberg G . Expression of cyclin D1, D3, E, and p27 in human renal cell carcinoma analysed by tissue microarray. Br J Cancer. 2003; 88(9):1417-23. PMC: 2741051. DOI: 10.1038/sj.bjc.6600922. View

16.

Zhang H, Stallock J, Ng J, Reinhard C, Neufeld T . Regulation of cellular growth by the Drosophila target of rapamycin dTOR. Genes Dev. 2000; 14(21):2712-24. PMC: 317034. DOI: 10.1101/gad.835000. View

17.

Bhutani J, Sheikh A, Niazi A . Akt inhibitors: mechanism of action and implications for anticancer therapeutics. Infect Agent Cancer. 2013; 8(1):49. PMC: 4028840. DOI: 10.1186/1750-9378-8-49. View

18.

Lee H, Lee E, Rhee Y, Ahn K, Li G, Jiang C . An oriental herbal cocktail, ka-mi-kae-kyuk-tang, exerts anti-cancer activities by targeting angiogenesis, apoptosis and metastasis. Carcinogenesis. 2006; 27(12):2455-63. DOI: 10.1093/carcin/bgl104. View

19.

Kumagai T, Muller C, Desmond J, Imai Y, Heber D, Koeffler H . Scutellaria baicalensis, a herbal medicine: anti-proliferative and apoptotic activity against acute lymphocytic leukemia, lymphoma and myeloma cell lines. Leuk Res. 2006; 31(4):523-30. DOI: 10.1016/j.leukres.2006.08.019. View

20.

Lin J, Wei L, Chen Y, Liu X, Hong Z, Sferra T . Pien Tze Huang induced apoptosis in human colon cancer HT-29 cells is associated with regulation of the Bcl-2 family and activation of caspase 3. Chin J Integr Med. 2011; 17(9):685-90. DOI: 10.1007/s11655-011-0846-4. View